Cancer-Associated Thrombosis, Low-Molecular- Weight Heparin, and the Patient Experience: A Qualitative Study

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s58595
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cerebral Venous Thrombosis: An Experience With Anticoagulation With Low Molecular Weight Heparin

Indian Journal of Critical Care Medicine
Critical CareIntensive Care Medicine
2005English

Single Centre Experience of the Management of Superficial Vein Thrombosis With Prophylactic Low-Molecular-Weight Heparin

British Journal of Haematology
Hematology
2017English

Heparin, Low Molecular Weight Heparin, and Derivatives in Thrombosis, Angiogenesis, and Inflammation: Emerging Links

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2007English

Low Molecular Weight Heparin

Reactions Weekly
2014English

Low Molecular Weight Heparin

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
1992English

Low Molecular Weight Heparin

Reactions Weekly
2013English

Low Molecular Weight Heparin

2020English

Low Molecular Weight Heparin or Unfractionated Heparin in the Treatment of Patients With Uncomplicated Deep Vein Thrombosis

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2000English

A Case of Portal Vein Thrombosis in Acute Necrotizing Pancreatitis Treated With Low-Molecular-Weight Heparin

Korean Journal of Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy